quipazine has been researched along with gepirone in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cleves, AE; Jain, AN; Kirshner, D; Langham, JJ; Spitzer, R | 1 |
| Eison, AS; Gianutsos, G; Hyslop, DK; Ryan, E; Taylor, DP; Yocca, FD | 1 |
| Eison, AS; Margraf, RR; Wright, RN; Yocca, FD | 1 |
| Eison, AS; Yocca, FD | 1 |
4 other study(ies) available for quipazine and gepirone
| Article | Year |
|---|---|
Physical binding pocket induction for affinity prediction.
Topics: Binding Sites; Ligands; Models, Molecular; Neural Networks, Computer; Peptide Fragments; Protein Binding; Receptor, Serotonin, 5-HT1A | 2009 |
Unique modulation of central 5-HT2 receptor binding sites and 5-HT2 receptor-mediated behavior by continuous gepirone treatment.
Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Behavior, Animal; Cerebral Cortex; Down-Regulation; Male; Norepinephrine; Pyrimidines; Quipazine; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Serotonin; Time Factors | 1991 |
8-OH-DPAT and buspirone analogs inhibit the ketanserin-sensitive quipazine-induced head shake response in rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Buspirone; Head; Ketanserin; Male; Naphthalenes; Pindolol; Pyrimidines; Quinolines; Quipazine; Rats; Rats, Inbred Strains; Receptors, Serotonin; Stereotyped Behavior; Tetrahydronaphthalenes | 1990 |
Reduction in cortical 5HT2 receptor sensitivity after continuous gepirone treatment.
Topics: Animals; Anti-Anxiety Agents; Cerebral Cortex; Dose-Response Relationship, Drug; Female; Humans; Male; Pyrimidines; Quipazine; Rats; Receptors, Serotonin; Spiperone; Stereotyped Behavior | 1985 |